CDP Venture Capital

GenomeUp is a Rome-based healthtech startup that specializes in AI-powered solutions for genetic analysis and clinical decision support. The company aims to serve as a global reference platform to enhance clinical decision-making for hospitals, laboratories, research centers, and pharmaceutical companies. By providing tools that accelerate diagnosis times and improve patient care, GenomeUp seeks to deliver actionable insights for health prevention within a 24-hour timeframe. Emphasizing its commitment to social responsibility, the company has evolved into an Italian Benefit Corporation, prioritizing sustainable and transparent practices that consider the well-being of stakeholders, communities, and the environment.

Salute360 is an online platform offering healthcare information and related services. It enables users to book consultations with healthcare professionals, order medicines for home delivery within hours, and connect with local pharmacists.

Genoa Instruments develops advanced super-resolution optical microscopes for biomedical research. Its innovative platform integrates spatial and temporal resolution, enabling high-detail imaging of living samples. The company aims to democratize access to high-resolution imaging, driving scientific discovery and healthcare research.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

Founded in 2018, Restorative Neurotechnologies designs and develops non-invasive neuromodulation devices for cognitive rehabilitation. The company aims to provide innovative solutions for rehabilitation and cognitive enhancement.

Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.

Genespire is a biotechnology company dedicated to developing innovative gene therapies for patients suffering from genetic diseases, with a particular emphasis on primary immunodeficiencies and inherited metabolic disorders. The company specializes in creating therapies that utilize integration-defective lentiviral vectors combined with gene editing techniques. This approach allows for highly effective and adaptable targeted insertion of therapeutic genes into blood cells, providing patients with a range of tailored therapeutic options suited to their specific conditions. By focusing on transformative solutions, Genespire aims to significantly improve the lives of individuals affected by severe genetic disorders.

BionIT Labs is a company focused on integrating information technology with bionic solutions to enhance the lives of individuals with disabilities. The firm specializes in developing advanced myoelectric hand prostheses that cater to people with upper limb differences. These innovative prosthetic hands utilize two motors to control the movement of all fingers, allowing for automatic adaptation to the shape and dimensions of objects being grasped. By creating more intuitive and functional prosthetic devices, BionIT Labs aims to empower users to navigate everyday challenges and improve their quality of life.

AGADE specializes in robotic exoskeletons. Its flagship product, AGADEXO, significantly reduces muscle fatigue and injury risks associated with repetitive tasks by providing variable support, mimicking zero-gravity movements.

Caracol AM, founded in 2015 and based in Lomazzo, Italy, specializes in additive manufacturing technology, providing customized design-to-production services across various industries. The company focuses on product design, concept development, and large-scale prototyping, alongside the production of finished parts. It also offers support for internalizing 3D printing and provides training and workshops for additive manufacturing. Caracol AM serves a diverse range of sectors, including automotive, aerospace, defense, industrial machinery, medical devices, oil and gas, design, architecture, and art. By leveraging its expertise in generative design and extensive knowledge of the industrial goods sector, Caracol AM aims to address the limitations of traditional manufacturing processes, positioning itself as a comprehensive partner for all additive manufacturing needs.

Salute360 is an online platform offering healthcare information and related services. It enables users to book consultations with healthcare professionals, order medicines for home delivery within hours, and connect with local pharmacists.

BionIT Labs is a company focused on integrating information technology with bionic solutions to enhance the lives of individuals with disabilities. The firm specializes in developing advanced myoelectric hand prostheses that cater to people with upper limb differences. These innovative prosthetic hands utilize two motors to control the movement of all fingers, allowing for automatic adaptation to the shape and dimensions of objects being grasped. By creating more intuitive and functional prosthetic devices, BionIT Labs aims to empower users to navigate everyday challenges and improve their quality of life.

Neuron Guard is a medical device company based in Modena, Italy, developing a targeted temperature management system to protect the brain after acute injury. The core offering is a refrigerating collar paired with a smart control unit that enables rapid cooling or warming of the patient, usable at the scene, in transit, or in hospital. The system aims to reduce neural lesions and preserve functions such as speech, vision, movement, and breathing by maintaining an optimal body temperature for up to 24-36 hours. The collar is designed for easy cleaning and safety, and the control unit records treatment data and connects with an emergency response system. The company envisions widespread adoption of its device as a standard of care for acute brain damage, integrating continuous temperature management as part of emergency and critical care workflows.

Weart is a company specializing in haptic technology, which translates science fiction concepts into practical applications. Their primary focus is on developing wearable and portable devices that digitalize the sense of touch. This technology allows users to augment VR/AR or multimedia content by providing realistic tactile sensations, including forces, vibrations, and temperature changes. These capabilities enhance various experiences such as medical and industrial training sessions in virtual reality, as well as instore shopping and e-commerce through tactile feedback. Weart's innovation records and reproduces user interactions with objects, offering a comprehensive haptic experience that combines texture, temperature, and force sensations.

Existo S.r.l. is a developer of innovative wearable technology aimed at enhancing human capabilities in daily living. The company's flagship product, Sixto, is a sixth robotic finger that serves as a wearable grasping device. Sixto features a single degree of freedom, allowing it to create a hybrid grasping mechanism that integrates with the user's hand. This technology not only augments the hand's grasping ability but also provides an intelligent holding point and can be personalized with interchangeable modules to suit various needs. Additionally, Sixto enables users to extend their grip away from the hand, making it particularly useful in potentially hazardous environments. The device is designed to assist individuals with disabilities by compensating for missing hand functions and improving overall functional scope.

GreenBone specializes in the development of innovative bone implants derived from bamboo wood, designed to address severe fractures and conditions that lead to significant bone loss, such as trauma and tumors. The company’s technology transforms bamboo into hydroxyapatite, a widely utilized biomaterial that serves as a bone graft scaffold. These biomimetic, reabsorbable implants possess the necessary weight-bearing and bone regeneration properties to effectively treat non-union fractures. Founded by a research group from ISTEC-CNR of Faenza, GreenBone aims to provide bio-inspired solutions that can significantly improve patient outcomes in orthopedic care.

BionIT Labs is a company focused on integrating information technology with bionic solutions to enhance the lives of individuals with disabilities. The firm specializes in developing advanced myoelectric hand prostheses that cater to people with upper limb differences. These innovative prosthetic hands utilize two motors to control the movement of all fingers, allowing for automatic adaptation to the shape and dimensions of objects being grasped. By creating more intuitive and functional prosthetic devices, BionIT Labs aims to empower users to navigate everyday challenges and improve their quality of life.

WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

Founded in 2018, Restorative Neurotechnologies designs and develops non-invasive neuromodulation devices for cognitive rehabilitation. The company aims to provide innovative solutions for rehabilitation and cognitive enhancement.

InnovHeart is a medical device company that develops transcatheter mitral valve replacement systems to treat mitral valve disease. Its implant technology is designed to replace diseased mitral valves using a transcatheter approach, enabling hospitals to perform safer and more accessible valve replacement procedures. The company aims to provide a safe, effective, and easy-to-use solution for patients suffering from mitral valve dysfunction.